Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for screening skin barrier function enhancing agent based on epidermal serine racemase and/or d-serine level, and skin barrier function evaluation method

a skin barrier and function-enhancing agent technology, applied in the direction of biological material analysis, plant/algae/fungi/lichens ingredients, peptides, etc., can solve the problems of dermatitis and allergy, skin moisture loss, and significant burden on the skin, so as to improve or enhance the skin barrier function

Inactive Publication Date: 2016-03-10
SHISEIDO CO LTD
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent text describes a method for selecting drugs that can improve the barrier function of the skin. This method allows for the evaluation of skin barrier function at different levels, such as the cellular level, tissue level, or biochemical level. The technical effect of this invention is that it provides a reliable tool for identifying effective drugs for improving skin barrier function.

Problems solved by technology

When skin barrier function is lost, skin moisture is also lost and infiltration of exterior foreign matter occurs, creating a condition of sensitive and dry skin and skin roughening, and potentially resulting in dermatitis and allergy.
When the degree of penetration of an indicator substance is to be used as the indicator of skin barrier function, the pigment or other indicator substance must be applied onto the skin, creating a significant burden on the skin.
In order to perform screening of drugs with effects of increasing skin barrier function from among numerous candidate drugs it is possible to use TEWL as the indicator of skin barrier function for in vivo experimentation, but this is unstable and significantly affected by the measuring environment, and it has been difficult to accomplish screening of drugs with an effect of increasing the physiological and structural skin barrier function from among numerous candidate drugs.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for screening skin barrier function enhancing agent based on epidermal serine racemase and/or d-serine level, and skin barrier function evaluation method
  • Method for screening skin barrier function enhancing agent based on epidermal serine racemase and/or d-serine level, and skin barrier function evaluation method
  • Method for screening skin barrier function enhancing agent based on epidermal serine racemase and/or d-serine level, and skin barrier function evaluation method

Examples

Experimental program
Comparison scheme
Effect test

example 1

Verification of Relationship Between D-Serine Content and Barrier Function in Stratum Corneum

[0069]The subjects were 57 volunteers having healthy test sites, and the test sites wetted by rinsing after cleaning by a prescribed method were allowed to stand for 30 minutes at constant temperature, constant humidity conditions (room temperature: 22° C., humidity: 45%). Next, the transepidermal water loss (TEWL) was measured with a Vapometer (Delfin Co.). Measurement was performed 3 times and the average value was subsequently used for analysis. Next, the stratum corneum at the TEWL-measured site was stripped twice using adhesive tape and the second was used for extraction of amino acids in a 95% methanol aqueous solution. The optical isomers of the extracted amino acids were analyzed by a reported method (reference: Yurika Miyoshi et al., Journal of Chromatography B, 877 (2009) 2506-2512). The results are summarized below. The extracted amino acids were subjected to fluorescent derivatiz...

example 2

Variation in D-Serine Content with Induced Differentiation of Keratinocytes

Cell Culturing and Drug Preparation

[0071]Normal human keratinocytes were seeded in a 24 well multiplate to a cell density of 2.5×104 cells / well, and cultured in KGM culture medium (Kurabo Industries, Ltd.) under conditions of 37° C., 5% CO2. After 3 days, the medium was exchanged with KGM culture medium to which 1.8 mM calcium chloride and 10 mM L-serine had been added (test group), or KGM culture medium to which 10 mM L-serine alone had been added (control group), and culturing was continued for another 2 days.

HPLC Sample Preparation and Free D-Serine Analysis by HPLC.

[0072]After rinsing cells with PBS, 500 μL of a 5% trichloroacetic acid aqueous solution was added, the cells were thoroughly dispersed and recovered, and ultrasonic treatment was performed for 30 minutes on ice, after which centrifugal separation was performed to obtain a supernatant. The amino acids in the supernatant were extracted by additi...

example 3

Screening of Candidate Drugs

Cell Culturing and Drug Preparation

[0073]Normal human keratinocytes were seeded in a 24 well multiplate to a cell density of 2.5×104 cells / well, and cultured in KGM culture medium (Kurabo Industries, Ltd.) under conditions of 37° C., 5% CO2. After 3 days, the medium was exchanged with KGM culture medium containing 1.8 mM calcium chloride, 10 mM L-serine and the candidate drug diluted solution, and culturing was continued for another 2 days. Seven drugs were used as candidate drugs, of which one was a 0.5% hydrolyzed oat protein solution.

HPLC Sample Preparation and Free D-Serine Analysis by HPLC.

[0074]After rinsing cells with PBS, 500 μL of a 5% trichloroacetic acid aqueous solution was added, the cells were thoroughly dispersed and recovered, and ultrasonic treatment was performed for 30 minutes on ice, after which centrifugal separation was performed to obtain a supernatant. The amino acids in the supernatant were extracted by addition of a 20-fold amoun...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
humidityaaaaaaaaaa
temperatureaaaaaaaaaa
pHaaaaaaaaaa
Login to View More

Abstract

The object of the invention is to develop a screening method for drugs having effects of increasing skin barrier function in in vitro experimentation, and to evaluate skin barrier function for skin. Serine racemase activity and / or expression level are used as an indicator to allow screening of candidate drugs.

Description

TECHNICAL FIELD[0001]The present invention relates to a method for screening a skin barrier function enhancing agent, and to a method for evaluating a skin barrier function for skin.BACKGROUND ART[0002]When skin barrier function is lost, skin moisture is also lost and infiltration of exterior foreign matter occurs, creating a condition of sensitive and dry skin and skin roughening, and potentially resulting in dermatitis and allergy. From the viewpoint of developing functional foods, cosmetics and pharmaceuticals, therefore, it is desirable to develop drugs that can increase skin barrier function. Factors for increasing skin barrier function include methods of increasing the amount of intercellular lipids or arranging their orientation, and drugs such as disclosed in PTL 1 have been developed that promote production of intercellular lipids.[0003]Indicators for skin barrier function include transepidermal water loss (TEWL) and the degree of penetration into skin using an indicator su...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): G01N33/50A61K36/28A61K36/9068A61K38/01C12Q1/68
CPCG01N33/5044G01N33/5038C12Q1/6876A61K38/011C12Q2600/158A61K36/28G01N2500/10C12Q2600/136A61K36/9068G01N33/6812G01N2333/968G01N2800/20C12Q1/6883C12Q2600/148A61K36/899A61K8/9789A61K8/9794A61K2300/00A61K8/645A61K2800/782A61Q19/00G01N2333/99
Inventor TOJO, YOSUKELINO, MASATOMIZUMOTO, CHIEKOYOSHIDA, YUZOMORI, HISASHI
Owner SHISEIDO CO LTD